The increase is expected from sales both in Ukraine and on export markets. This year, according to the Company’s forecasts, the share of exports will be 33%. In 2017, Farmak’s share of sales on foreign markets was 31%.
According to the results of the first half of 2018, Farmak JSC’s export volume increased by 13% due to the increase in supplies to Uzbekistan by 20%, Belarus by 124%, Kazakhstan by 13%, Kyrgyzstan by 16%, as compared with the first half of 2017. At the same time, the volume of sales to the Russian Federation remained at the level of 2017.
“We strive to increase the Company’s export potential, while retaining our leadership positions in Ukraine. This will help increase production volumes, create new jobs, increase the amount of taxes paid. For Farmak, the EU and Asian markets remain the priority”, said Volodymyr Kostiuk, Executive Director of Farmak JSC.
Overall, in 2017, exports amounted to USD 70 million. At year-end, Poland, Uzbekistan and Russia prevailed in the foreign sales structure. In particular, sales to Poland amounted to 28.3% of Farmak JSC’s total exports, to Uzbekistan – 20.9%, and to Russia – 16.7%.
As part of the celebration of the 60th anniversary of the first release of Corvalol manufactured by Farmak, leader of the Ukrainian pharmaceutical market, the Ukrainian Book of Records has recognized Corvalol by Farmak as the most known sedative in Ukraine. Corvalol by Farmak is a globally known medicinal product that has already become a […]
On Sunday, February 24, the final matches within UFAM League 3rd season (Kyiv Open Futsal Championship among health care institutions) took place. The tournament which started at the end of 2018 was ended with the great sport and health event. 12 teams participated in the competition this year, including the players from the Cardiology Institute, Kyiv [&hell...
Компанія зайняла перше місце серед найбільших компаній у рейтингу «Виробництво ліків» Також ПАТ «Фармак» увійшов до рейтингів: «Рейтинг найбільших експортерів», «Рейтинг найбільших платників податків», «Рейтинг компаній по об’єму виручки». ПАТ «Фармак» – національний виробник лікарських засобів європейського ринку. Завдяки високій якості продукції та ...